Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Lucid Diagnostics Inc. | Chief Financial Officer | Common stock | 1.04M | $1.46M | $1.40 | May 7, 2024 | Direct |
DarioHealth Corp. | Director | Common Stock | 155K | $961K | $6.21 | Mar 6, 2024 | Direct |
PAVmed Inc. | President & CFO | Common stock | 755K | $471K | $0.62 | Mar 28, 2022 | Direct |
CITIUS ONCOLOGY, INC. | Director | Stock Option (Right to Buy) | 150K | Aug 12, 2024 | Direct | ||
Citius Pharmaceuticals, Inc. | Director | Options to Purchase Common Stock | 75K | Oct 10, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
CTOR | CITIUS ONCOLOGY, INC. | Aug 12, 2024 | 1 | $0 | 4 | Aug 14, 2024 | Director |
CTOR | CITIUS ONCOLOGY, INC. | Aug 12, 2024 | 0 | $0 | 3 | Aug 14, 2024 | Director |
LUCD | Lucid Diagnostics Inc. | May 7, 2024 | 1 | $0 | 4 | May 8, 2024 | Chief Financial Officer |
DRIO | DarioHealth Corp. | Mar 6, 2024 | 1 | $0 | 4 | Mar 8, 2024 | Director |
CTXR | Citius Pharmaceuticals, Inc. | Oct 10, 2023 | 1 | $0 | 4 | Oct 12, 2023 | Director |
CTXR | Citius Pharmaceuticals, Inc. | Feb 7, 2023 | 1 | $0 | 4 | Feb 9, 2023 | Director |
CTXR | Citius Pharmaceuticals, Inc. | Feb 7, 2023 | 0 | $0 | 3 | Feb 9, 2023 | Director |
DRIO | DarioHealth Corp. | Dec 21, 2022 | 1 | -$39.2K | 4 | Dec 23, 2022 | Director |
DRIO | DarioHealth Corp. | May 18, 2022 | 1 | $0 | 4 | May 20, 2022 | Director |
PAVM | PAVmed Inc. | Mar 28, 2022 | 1 | -$236K | 4 | Apr 11, 2022 | President & CFO |
PAVM | PAVmed Inc. | Feb 18, 2022 | 1 | $0 | 4 | Feb 23, 2022 | President & CFO |
LUCD | Lucid Diagnostics Inc. | Feb 18, 2022 | 1 | $0 | 4 | Feb 23, 2022 | Chief Financial Officer |
LUCD | Lucid Diagnostics Inc. | Jan 7, 2022 | 1 | $0 | 4 | Jan 10, 2022 | Chief Financial Officer |
LUCD | Lucid Diagnostics Inc. | Oct 13, 2021 | 0 | $0 | 3 | Oct 13, 2021 | Chief Financial Officer |
DRIO | DarioHealth Corp. | May 26, 2021 | 2 | -$1.15M | 4 | May 28, 2021 | Director |